Literature DB >> 24888567

The non-reverse transcriptase activity of the human telomerase reverse transcriptase promotes tumor progression (review).

Yong Qin1, Hong Guo1, Bo Tang1, Shi-Ming Yang1.   

Abstract

In human cancer, high expression of telomerase is correlated with tumor aggressiveness and metastatic potential. Human telomerase reverse transcriptase (hTERT), which regulates telomere length, can promote tumor development. Most research on hTERT has been focused on its crucial function of telomere maintenance. However, there are many phenomena that cannot be explained by its reverse transcriptase activity. Accumulating evidence suggests that hTERT has functions independent of its protective function at the telomere ends, such as increasing the anti-apoptotic capacity of cells, enhancing DNA repair, maintaining stem cells and regulating gene expression. This review will provide an update on the non-reverse transcriptase activity of hTERT and its contribution to tumor formation, metastasis and cancer stem cell maintenance. Repression of the non-reverse transcriptase activity of hTERT may be a new strategy for tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24888567     DOI: 10.3892/ijo.2014.2470

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  Upregulated human telomerase reverse transcriptase (hTERT) expression is associated with spinal chordoma growth, invasion and poor prognosis.

Authors:  Ming-Xiang Zou; Guo-Hua Lv; Jing Li; Xiao-Ling She; Yi Jiang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

2.  Human telomerase reverse transcriptase protein expression is associated with survival in patients with oral squamous cell carcinoma.

Authors:  Kazuya Haraguchi; Manabu Habu; Naomi Yada; Masaaki Sasaguri; Izumi Yoshioka; Kazuhiro Tominaga
Journal:  Int J Clin Exp Pathol       Date:  2022-01-15

3.  Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma.

Authors:  Noelyn A Hung; Ramona A Eiholzer; Stenar Kirs; Jean Zhou; Kirsten Ward-Hartstonge; Anna K Wiles; Chris M Frampton; Ahmad Taha; Janice A Royds; Tania L Slatter
Journal:  Mod Pathol       Date:  2016-01-15       Impact factor: 7.842

4.  hTERT promotes gastric intestinal metaplasia by upregulating CDX2 via NF-κB signaling pathway.

Authors:  Bai-Jun Chen; Shuo Zeng; Rui Xie; Chang-Jiang Hu; Su-Ming Wang; Yu-Yun Wu; Yu-Feng Xiao; Shi-Ming Yang
Journal:  Oncotarget       Date:  2017-04-18

5.  An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.

Authors:  Yong Qin; Bo Tang; Chang-Jiang Hu; Yu-Feng Xiao; Rui Xie; Xin Yong; Yu Yun Wu; Hui Dong; Shi-Ming Yang
Journal:  Oncotarget       Date:  2016-01-05

6.  Genetic profile and biological implication of PIN2/TRF1-interacting telomerase inhibitor 1 (PinX1) in human cancers: an analysis using The Cancer Genome Atlas.

Authors:  Wei-Juan Huang; Mei Li; Xiao-Han Jin; Xiao-Jia Huang; Wei Zhao; Xiao-Peng Tian
Journal:  Oncotarget       Date:  2017-06-21

7.  One-Two Punch Therapy for the Treatment of T-Cell Malignancies Involving p53-Dependent Cellular Senescence.

Authors:  Yingjie Qing; Hui Li; Yunzi Zhao; Po Hu; Xiangyuan Wang; Xiaoxuan Yu; Mengyuan Zhu; Hongzheng Wang; Zhanyu Wang; Qinglong Guo; Hui Hui
Journal:  Oxid Med Cell Longev       Date:  2021-09-21       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.